Escalon Medical Corp (ESMC) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Escalon Medical Corp   (ESMC)


Escalon Medical's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Escalon Medical's ROI in the fourth quarter of 2026?
Escalon Medical Corp achieved a return on average invested assets (ROI) of 63.96 % in its fourth quarter of 2026, this is above ESMC's average return on investment of -9.99%.
Escalon Medical Corp invested over the 12 months ending in its fourth quarter of 2026 $4 million

ROI has improved compared to 51.88% in the third quarter of 2026, due to net income growth.

Within the Healthcare sector 23 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 2771, from total ROI ranking in the third quarter of 2026 at 3391.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 91.57 % 42.45 % 23.28 % 13.41 % 7.26 %
Y / Y Net Income Change TTM 599.56 % - 227.54 % -45.64 % 199.64 %
Investment (TTM) in Millions 8 5 2 2 2
Return On Investment (TTM) 63.96 % 51.88 % 11 % 4.45 % 17.52 %
ESMC's Overall Ranking # 2771 # 3391 # 2847 # 3110 # 2961
Seq. Investment Change TTM 41.67 % 26.04 % 4.96 % 2.21 % 5.35 %
Seq. Net Income Change TTM 74.66 % 494.74 % 159.12 % -74.01 % -
Net Income (TTM) in Millions 3 2 0 0 0

ESMC Company Profile >> Back to ESMC Roi Comparisons >> See Annual ESMC Return On Investment



Return On Investment ESMC's Ranking
Within: No.
Industry # 5
Sector # 24
Overall # 2771

Return On Investment Statistics
High Average Low
64.7 %
-9.99 %
-95.2 %
(Jun 30 2026)   (Dec 31 2013)







Financial Statements
Escalon Medical's IV. Quarter Investments $ 8 Millions ESMC's Balance sheet
Escalon Medical's IV. Quarter Income $ 2 Millions Quarterly ESMC's Income Statement
ESMC's Income by Division See ESMC's Income by Division


ESMC Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 7 2 2 2 2
Y / Y Investment Growth 226.44 % 3.33 % -12.5 % 44.39 % -33.09 %
Net Income in Millions 4 0 0 0 0
Y / Y Net Income Growth 4940.99 % - - 1408.84 % -
Annual Return On Investment 59.54 % 3.86 % -6.27 % 11.96 % 1.14 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 59.54 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ESMC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ESMC's Competitors
Subscribers only: Roi for Escalon Medical's Suppliers
Subscribers only: Return On Investment for ESMC's Customers

Other Ratios
ESMC's Roa ESMC's Inventory Turnover Ratio ESMC's Growth Rates ESMC's Dividend Statistics
ESMC's Profitability Ratios ESMC's Asset Turnover Ratio ESMC's Dividend Growth
ESMC's Roe ESMC's Valuation Ratios ESMC's Financial Strength Ratios ESMC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Advanced Biomed Inc.  101.54 %
Interpace Biosciences Inc   100.71 %
Sanuwave Health Inc   91.81 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Escalon Medical Corp   64.70 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %

Date modified: 2026-10-17T15:14:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.